TransMedics (TMDX) Enterprise Value (2018 - 2026)

TransMedics' Enterprise Value history runs 9 years deep, the most recent figure standing at -$461.7 million for Q1 2026.

• In Q1 2026, Enterprise Value fell 48.87% year-over-year to -$461.7 million; the TTM figure through Mar 2026 stood at -$461.7 million (down 48.87% YoY), while the FY2025 annual figure was -$488.4 million, down 45.07% from the prior year.
• Enterprise Value was -$461.7 million for Q1 2026 at TransMedics, up from -$488.4 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$58.1 million in Q2 2022 to a low of -$582.2 million in Q2 2023.
• Historically, Enterprise Value has averaged -$334.6 million across 5 years, with a median of -$350.2 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Enterprise Value soared 48.26% in 2022, then sank 902.36% in 2023.
• A 5-year view of Enterprise Value shows it stood at -$201.2 million in 2022, then tumbled by 96.25% to -$394.8 million in 2023, then gained by 14.73% to -$336.6 million in 2024, then slumped by 45.07% to -$488.4 million in 2025, then gained by 5.46% to -$461.7 million in 2026.
• The last three Enterprise Value figures came in at -$461.7 million (Q1 2026), -$488.4 million (Q4 2025), and -$466.2 million (Q3 2025), per Business Quant data.